Growth arrest and cell cycle progression are regulated by the retinoblastoma tumour suppressor pRB and related proteins p130 and p107 that bind to and inhibit the E2F family of transcription factors. Although the precise mechanism of this inhibition remains to be established, previous studies indicated the presence of transcriptional repression activity in the`pocket' of RB family members. We show here that RBP1, a known pRB pocket-binding protein, possesses transcriptional repression activity and associates with p130-E2F and pRB-E2F complexes speci®cally during growth arrest. Overexpression of RBP1 both inhibited E2F-dependent gene expression and suppressed cell growth. Thus repression of E2F-dependent transcription by RBP1 via RB family members may play a central role in inducing growth arrest.
Introduction
Control of gene expression by the E2F/DP family of transcription factors (La Thangue, 1994; Nevins, 1992) (known collectively as E2F) plays an important role in the cell cycle and growth arrest as E2F regulates expression of a number of genes required for DNA synthesis and cell cycle progression (Chellapan et al., 1991; ). E2F appears to be a major target of the retinoblastoma (RB) family of growth suppressors, pRB, p130 and p107, that bind to and inhibit E2F (La Thangue, 1994; Nevins, 1992) . Interactions between the E2F and RB families are cell cycle-dependent. pRB-E2F complexes are found throughout the cell cycle and in growth-arrested cells, and inhibition of E2F activity appears to be regulated at least in part by phosphorylation of pRB by cyclindependent protein kinases (Cdk) (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Mihara et al., 1989) . p107-E2F complexes are found largely in late G1 and S-phase and may contribute to cell cycle progression (Lees et al., 1992; Shirodkar et al., 1992) . p130-E2F complexes are prominent in growth-arrested cells (Chittenden et al., 1993; Cobrinik et al., 1993) and we (Corbeil et al., 1995; Corbeil and Branton, 1997) and others (Smith et al., 1996) have observed the appearance of a large novel complex in association with exit from the cell cycle and terminal differentiation. This p130-E2F complex, termed C7 by our group, was shown to lack Cdk2 and cyclins, but because of its slow migration in E2F-speci®c electrophoretic mobility shift assays (EMSA), it appeared to contain one or more additional proteins (Corbeil and Branton, 1997) . Preliminary evidence (Corbeil and Branton, 1997) suggested that such proteins interact with p130 via a site in the`pocket' similar to that utilized by the adenovirus E1A protein which binds via a conserved Leu-X-Cys-X-Glu motif found in several other viral and cellular RB-binding proteins. A number of large and often relatively poorly characterized cellular proteins have been identi®ed that contain this binding motif and that have been observed to interact with RB family members, including RBP1 and RBP2 (DefeoJones et al., 1991; Fattaey et al., 1993; Kaelin et al., 1992; Kim et al, 1994; Otterson et al., 1993) , BRG1 and BRM (Dunalef et al., 1994; Strober et al., 1996) , RIZ (Buyse et al., 1995) , and HBP1 (Tevosian et al., 1997) . It seemed possible that one or more of these species might be components of the C7 p130-E2F complex.
Results and discussion

Identi®cation of RBP1-containing E2F complexes
Our present studies have concentrated on RBP1 as the existence of good mouse monoclonal antibodies to this polypeptide, termed LY11 (DeCaprio, unpublished) , made further analysis possible. Figure 1a shows that LY11 serum immunoprecipitated a species of about 200 kDa from human H1299 cells labeled with 35 S-methionine/cysteine, as found by others (Defeo-Jones et al., 1991; Otterson et al., 1993) . These immunoprecipitations were carried out under mild conditions that preserve protein complexes. Thus in addition to this 200 kDa polypeptide, several other species were evident, including a major species that migrated as a protein of about 48 kDa, and more minor species of about 110 and 130 kDa which were not present using a control antibody against hemagglutination antigen (HA.11). We do not know the identities of the 48 kDa protein or several other minor species evident with LY11, but the 110 kDa species probably represents pRB as it co-migrated with protein immunoprecipitated by monoclonal antibody IF8 raised against the`pocket' of pRB (Santa Cruz). As will be discussed below, we believe that RBP1 interacts both with pRB and p130, and thus the 130 kDa species present with LY11 antibody probably represents the p130 RB family member. Similar results were also obtained in monkey CV-1 cells (data not shown). S-methionine/ cysteine labeled cell lysates were immunoprecipitated either with anti-RBP1 serum LY11, anti-pRB serum IF8, or (non-speci®c) anti-HA serum HA.11. Immunoprecipitated proteins were then resolved by SDS ± PAGE using 7.5% polyacrylamide gel. (b) Both asynchronously growing and serum starved CV-1 cell extracts were subjected to EMSA by incubating with 32 P labeled E2F-speci®c oligonucleotide. Dierent E2F/DNA complexes were resolved by 4% non-denaturing polyacrylamide gel electrophoresis. Components of the E2F complexes were identi®ed by antibody`supershift' experiments as described in Materials and methods. Lane 1 ± asynchronously growing cells. Lanes 2 ± 4 ± extracts from asynchronously growing cells incubated in the presence anti-pRB 896 serum (lane 2), anti-p107 serum SD9 (lane 3), or anti-p130 serum C-20 (lane 4). Lane 5 ± serum-starved cells. Lanes 6 ± 8 ± extracts from serum-starved cells incubated in the presence of anti-pRB (lane 6), anti-p107 (lane 7) or anti-p130 (lane 8) sera. Lanes 9 ± 12 ± asynchronously growing cells (lanes 9); serum-starved cells (lane 10) or extracts from serum-starved cells incubated in the presence of anti-p130 antibody (lane 11) or anti-RBP1 serum LY11 (lane 12). Lanes 9A to 12A ± the same samples as in lanes 9 to 12 but analysed by PAGE using a polyacrylamide:bis-acrylamide ratio of 19:1. The positions of C7, and pRB-containing E2F complexes (RB) have been presented as have those of`supershifted' complexes (*C7 and *RB)
To determine if RBP1 is present in E2F complexes, monkey CV-1 cells were harvested either from rapidly growing or serum-starved growth-arrested cultures and cell extracts were subjected to electrophoretic mobility shift assays (EMSA) using an E2F-speci®c radioactive oligonucleotide, as described previously (Corbeil and Branton, 1997) . Figure 1b shows, as found previously (Corbeil et al., 1995; Corbeil and Branton, 1997 ) that serum-starved (lanes 5 and 10) and asynchronously growing cells (lanes 1 and 9) contain a variety of E2F complexes; however, the large C7 complex was observed only in the former. No complexes were detected using an unrelated or altered E2F oligonucleotide (data not shown). The components of these E2F complexes were partially resolved through the addition of antibodies that recognize various RB family members. Addition of anti-pRB serum 896 caused a`supershift' of at least two faster migrating pRB-E2F complexes (termed RB in the ®gure) to slower migrating species (*RB) in both growing (lane 2) and serum-starved (lane 6) cells. No eect on the migration of C7 was observed with this serum (lane 6). Addition of anti-p107 antibody SD9 had little eect on any of the complexes (lanes 3 and 7); however, addition of C-20 serum speci®c for the carboxy terminus of p130 caused a`supershift' of C7 in extracts from growth-arrested cells (lanes 8 and 11). These results con®rmed that C7 contains p130-E2F complexes exclusively. As found previously (Corbeil and Branton, 1997) , anti-p130 serum also made evident the existence of more minor, faster-migrating p130-E2F complexes which were evident in lane 11, upon prolonged exposure of the gel (not shown). To determine if RBP1 is present in C7 or any of the other E2F complexes a similar experiment was conducted in asynchronously growing and serumstarved CV-1 cells using antiserum LY11 against human RBP1. Figure 1b (lane 12) shows that both C7 and the faster-migrating pRB-E2F complexes identi®ed in lane 2 were no longer apparent and that one or more new complexes (termed *RB in the ®gure) were evident. In addition, analysis of these same samples under dierent conditions of PAGE indicated the presence of an additional very slowly-migrating E2F complex (termed *C7 in the ®gure) that just barely entered the gel (lane 12A). Thus it appeared that C7 and certain pRB-E2F complexes in growth arrested cells contain RBP1.
Inhibition of E2F-dependent transcription by RBP1
To analyse the role of RBP1 in such complexes, rapidly growing C33A human cervical carcinoma cells, which are de®cient both for functional p53 and pRB, were analysed for their ability to regulate the E2F-1 promoter. This promoter was chosen because it contains E2F recognition sites that are tightly regulated during growth arrest by E2F-RB family complexes, particularly p130/E2F (Hsiao et al., 1994; Johnson et al., 1993 Johnson et al., , 1994 Johnson, 1995) . Cells were transfected with DNA from E2F1-Luc(Wt), a luciferase reporter construct driven by the E2F-1 promoter, together with that from pCMVRBP1-HA that encodes a haemagglutinin (HA) epitope-tagged wild-type RBP1 (Kaelin, unpublished) , or pCMVRBP1DLCE-HA that encodes a mutant form of RBP1 lacking the Leu-XCys-X-Glu p130/pRB binding site. In some cases cDNAs encoding pRB, p130 or the 243-residue product of human adenovirus type 5 12S E1A mRNA were also assayed. Figure 2a shows that co-transfection with increasing amounts of DNA expressing wild-type RBP1 resulted in decreasing levels of luciferase activity. Similar results were also obtained using increasing amounts of DNA expressing p130 or pRB. As expected, expression of E1A protein caused a large increase in luciferase activity. Conversely, co-transfection with increasing amounts of DNA expressing the mutant form of RBP1 lacking the pRB/p130 binding site [RBP1(DLCE)] had little eect on luciferase activity. To ensure that this eect by RBP1 was speci®c to E2F-regulated transcription, a similar study was carried out with the E2F1-luc(mE2F) reporter that contains four point mutations within the E2F recognition sites (Johnson, 1995) and that, by EMSA, fails to interact with E2F (Johnson et al., 1994) . Figure  2b shows that co-transfection with increasing amounts of DNA expressing RBP1(Wt), RBP1(DLCE) or pRB had no eect on luciferase activity. A small reduction was seen with p130 in this experiment; however, additional studies showed no such eect consistently and the maximum reduction seen in Figure 2b was only about 10% as compared to about 50% in Figure  2a using the wild-type E2F1-luc(Wt) reporter. Figure  2b also shows that the E2F1 promoter in E2F1-luc(mE2F) is nonetheless still active as expression of E1A protein resulted in about a three-fold stimulation of luciferase activity. It is likely that this eect was due to the presence of a series of Sp1 sites that respond to E1A protein . In total, the results in Figure 2a and b suggested that RBP1 represses expression of the E2F1 promoter through the E2F element in a pRB/p130-dependent fashion. To strengthen this contention further, a similar study was carried out in cells co-transfected with DNA expressing the wild-type E2F1-luc(Wt) reporter and a constant amount of either exogenous pRB or p130, plus increasing amounts of DNA encoding RBP1(Wt) or RBP1(DLCE). Figure 2c shows that in all cases, increased RBP1(Wt) expression caused a further reduction in luciferase activity. With RBP1(DLCE) such activity actually increased slightly with higher amounts. We believe that this eect may be due to squelching of the inhibitory eects of endogenous wildtype RBP1 that is expressed ubiquitously (Otterson et al., 1993) . A possible explanation is that repression by RBP1 may require interactions with an additional factor that is able to interact with RBP1(DLCE). In this case RBP1(DLCE) would therefore function as a dominant negative mutant.
Induction of growth arrest by RBP1
As the C7 complex containing RBP1 is only formed during growth arrest, it seemed possible that RBP1 might play a role in the control of cell proliferation by inhibiting E2F-dependent transcription, thus inducing, enhancing, or maintaining exit from the cell cycle. To determine if RBP1 suppresses cell growth, CV-1 cells were transfected with DNA from plasmids that express neo as well as RBP1. These included pRcCMVRBP1-HA that encodes an HA-tagged version of RBP1, pcDNA3Gal4RBP1 that contains RBP1 fused to the Gal4 DNA-binding motif, and pcDNA3Gal4RBP1dl-747C that encodes RBP1 lacking the Leu-X-Cys-X-Glu RB-binding sequence. Following transfection, cells were plated and allowed to growth under G418 selection. Figure 3a shows that no colonies were formed in the absence of neo (no vector). With pcDNA3Gal4RBP1dl-747C, a signi®cant number of large colonies were produced with a morphology similar to those obtained with pcDNA3 which lacks RBP1 coding sequences (Figure 3b ). With both of the plasmids expressing wild-type RBP1, a signi®cant reduction in colony formation was observed, about c Figure 2 Eect of RBP1 on E2F-dependent transcription. (a and b) Transactivation assays were performed in duplicate using growing human C33A cells plated at a density of 20610 5 on 60 mm-diameter dishes. E2F-speci®c activity was determined by measuring levels of luciferase activity in extracts from cells that were transiently transfected by the calcium phosphate precipitation method (Graham and van der Eb, 1973) with 3 mg of DNA from reporter plasmid E2F1-Luc(Wt) (a), which contains ®re¯y luciferase linked to an E2F-1 speci®c promoter, or E2F1-Luc(mE2F) (b), which contained mutated E2F recognition sites (Johnson, 1995) . Cells were also co-transfected with increasing amounts (from 1 ± 4 mg) of DNA from plasmids pCMVRBP1-HA (human RBP126), pCMVRBP1DLCE-HA (a deletion mutant lacking RBP1 residues 921 ± 1056 including the Leu-X-Cys-X-Gly binding site), and in some cases from plasmids expressing human pRB or p130, or the product of the 12S Ad5 E1A mRNA subcloned into pcDNA3 (Invitrogen) and expressed under the CMV promoter. In addition, 2 mg of RSV-b-GAL DNA were included to allow normalization of transfection eciency by measurement of b-galacosidase activity (PoÈ perl and Featherstone, 1992) . The total amount of DNA used in each assay was brought to 11 mg using DNA from pGEM and the total amount of CMV promoter containing plasmids were brought up to the same amount in each sample by addition by pcDNA3 DNA (Invitrogen). Cells were harvested at 40 h post-transfection and luciferase activity was measured as described elsewhere (Weintraub et al., 1995) . Results have been presented as a percentage of that obtained with reporter plasmid alone. (c) Eects of RBP1(Wt) and RBP1(DLCE) on expression of the E2F1 promoter were measured in C33A cells expressing exogenous pRb and p130. Cells were transfected with E2F1-Luc(Wt) as in a; however such cells were also co-transfected with 2 mg of plasmid DNA expressing pRb or p130 and increasing amounts (from 1 mg ± 3 mg) of DNA from plasmid pCMVRBP1-HA expressing RBP1(Wt) or plasmid pCMVRBP1DLCE-HA expressing the RBP1(DLCE) mutant. Luciferase activities were measured and have been presented as a percentage of levels obtained with reporter plasmid and pRb or p130 in the absence of pCMVRBP1-HA or pCMVRBP1(DLCE). The data represent the average of four separate experiments (+standard deviation) 75% in the case of pcDNA3Gal4RBP1, and 50% with pRcCMVRBP1-HA (Figure 3a ). In addition, the colonies formed with wild-type RBP1 were considerably smaller and were composed of only small numbers of sparse cells (see Figure 3b) . These results showed that over-expression of RBP1 induces growth arrest.
Identi®cation and mapping of repression activity associated with RBP1
To examine the mechanism by which RBP1 inhibits E2F activity, the GAL4 DNA binding sequence was fused with that of RBP1, and CHO cells were cotransfected with DNA encoding GAL4-RBP1 or other proteins, and G5TKCAT, a reporter construct that expresses CAT by GAL4-dependent transcription. Figure 4a shows that GAL4-RBP1, expressed either using the cytomegalovirus (CMV) or SV40 promoter, repressed transcription by about 80 ± 90%, as much as the adenovirus E1B-55 kDa product (Gal4AdE1B-55K) that is known to be a potent transcriptional repressor when linked to the Gal4 DNA binding domain (Yew et al., 1994; Teodoro et al., 1994; Teodoro and Branton, 1997) . RBP1-HA that was not linked to Gal4 (pRcCMVRBP1-HA) had no eect on expression. Thus RBP1 appears to function as a transcriptional repressor, but only when tethered to a promoter. GAL4-RBP1DLCE also exhibited similar Figure 4 Repression of Gal 4-dependent transcription by RBP1. (a) The RBP1 coding sequence or deletion mutants of RBP1 lacking various amounts at the carboxy terminus or truncated forms of RBP1 were fused to the GAL4 DNA binding domain in pcDNA3 under the control of the CMV promoter or in pSG424 under the SV40 promoter. Transcriptional repression was measured by determining the ability of GAL4-RBP1 constructs to reduce expression relative to that of pSG424 (GAL4 alone) of the G5TKCAT reporter that contains CAT linked to ®ve GAL4 DNA binding sites and the HSV minimal thymidine kinase (TK) promoter (Yew et al., 1994; Teodoro and Branton, 1997) . Assays were carried out in duplicate in CHO cells as in Figure 2 using 2.5 mg of DNA from G5TKCAT and 2.5 mg of RBP1 DNA. As negative controls, assays were also performed on cells transfected with DNA from pSG424 alone or pRcCMVRBP1-HA that lacks the GAL4 DNA binding sequence, and as a positive control with DNA from GAL4-Ad5E1B-55K which expresses the Ad5 E1B 55 kDa repressor. In addition, 2 mg of RSV-b-GAL DNA were also included to allow normalization of transfection eciency by measurement of b-galacosidase activity (PoÈ pperl and Featherstone, 1992) . Cells were harvested at 40 h post transfection and CAT assays were performed using thin layer chromatography followed by a RPB1 induces growth arrest A Lai et al b c quantitation using a Fuji BAS2000 phosphorimager, as described previously (Yew et al., 1994; Teodoro and Branton, 1997) . The data represent the average of four separate experiments (+standard deviation). (b) List of RBP1 deletion mutants and a summary of CAT activity as a percentage of control. (c) Expression of Gal4RBP1 and deletion mutants. 293T cells were transfected with Gal4RBP1 and all deletion mutants using the calcium phosphate method. Whole cell extracts were subject to SDS ± PAGE using 7.5% (lanes 1 ± 7) and 10% (lanes 8 ± 17) polyacrylamide gels. Western blotting was done using anti-Gal4DBD monoclonal antibody RK5C1 after the resolved proteins were transferred to PVDF membranes. The observed sizes of the mutants were very close to the expected sizes as shown in (c). repression activity, indicating that repression by RBP1 is independent of RB family binding when fused to a heterologous DNA binding domain. To identify the region of RBP1 required for repression, a series of deletion mutants was created in the GAL4-RBP1 construct in which increasing regions from the carboxy terminus of RBP1 were deleted (see Figure  4b ). All of these GAl4-RBP1 fusion products were expressed at high levels in both 293T cells (see Figure  4c ) and CHO cells (data not shown). Figure 4a (and summarized in Figure 4b ) shows that elimination of sequences encoding up to 805 residues from the carboxy terminus had little or no eect on repression activity; however, removal of additional sequences greatly reduced or eliminated repression. It is likely that these sequences are responsible for RBP1 repression activity. The portion of RBP1 between residues 388 and 599 contains a sequence predicted to encode an a-helical domain, preceded by a region, termed ARID, found in several other proteins, including the product of dead ringer (dri) from Drosophila melanogaster (Gregory et al., 1996) , SWI1/ ADR6 from yeast (CoteÂ et al., 1994) , B Cell Regulator of IgH Transcription (Bright) from mouse (Herrscher et al., 1995) , human Mrf1 and Mrf2A (Huang et al., 1996) , and RBP2 (Defeo-Jones et al., 1991; Fattaey et al., 1993; Kaelin et al., 1992 Kim et al., 1994 Otterson et al., 1993) . When this portion of RBP1 was fused to Gal4 (Gal4-RBP1-Rep), it repressed transcription at a level comparable to wild type Gal4-RBP1, as shown in Figure 4a and b, suggesting that this region is responsible for the transcriptional repression activity. The present results indicate that RBP1 represents a new and important regulator of growth arrest induced by p130 and pRB. Binding of RBP1 to these proteins introduces a transcriptional repressor into p130-E2F and pRB-E2F complexes, thus inhibiting E2F-driven gene expression and signalling or enhancing exit from the cell cycle. Regulation of such complexes is unclear as we have found that RBP1 is present throughout the cell cycle (Corbeil and Branton, unpublished) . Several reports have mapped repression of E2F by RB family members to the`pocket' of these proteins Starostik et al., 1996; Weintraub et al., 1995) . The present results indicate that such repression may result at least in part from complex formation with RBP1; however, it is also possible that RBP1 is only one representative of a class of RB-binding proteins with similar properties. For example, another p130/pRB-binding protein, HBP1, was recently indenti®ed (Tevosian et al., 1997) and shown to possess signi®cant transcriptional repression activity. This protein could perform a similar function in some cases, although unlike RBP1, which requires interactions with RB family members to exhibit repression of E2F-dependent transcription, HBP1 has been reported to bind directly to DNA and thus may be capable of repression via promoter binding sequences other than E2F sites. Our data indicate that repression by RBP1 maps to the ARID region and adjacent residues. As mentioned above, ARID-like regions are also present in a number of other transcriptional regulators and have been shown to interact with AT-rich DNA sequences (Gregory et al., 1996; CoteÂ et al., 1994; Herrscher et al., 1995; Huang et al., 1996) . How this property is linked to transcriptional repression is unclear; however, such interactions at E2F-dependent promoters may limit the ability of E2F to activate transcription. Our data also suggested that RBP1 may not function directly as a repressor, but rather may act as a linker which introduces an as yet unidenti®ed transcriptional repressor into p130/ pRB-E2F complexes. In this case the region we have identi®ed in RBP1 would function as a repressor binding site. One possibility is that RBP1 may interact with one or more histone deacetylases that have recently been linked to repression by the RB family of regulators (Brehm et al., 1998; Magnaghl-Jaulin et al., 1998; Luo et al., 1998) . Future studies are underway to clarify the molecular mechanism of repression by RBP1 and its role in the regulation of growth arrest.
Materials and methods
Cell culture and transfection
Monkey CV-1(ATCC CCL 70) and human lung carcinoma ± H1299 (Mitsudomi et al., 1992) cells were grown in Dulbecco's modi®ed eagle medium (D-MEM) containing 10% fetal calf serum. Human cervical carcinoma ± C33A (ATCC HTB-31), 293T cells, a variant of 293 cells (Graham et al., 1977) that express SV40 large T antigen and Chinese hamster ovary (CHO) cells (ATCC CCL-61) were grown in a-minimal essential medium supplemented with 10% fetal calf serum. In many experiment CV-1 cells were induced to stop proliferating by incubating in D-MEM containing 2% dialyzed calf serum for 72 h, as described previously (Corbeil and Branton, 1997) . Transfections were carried out by the calcium phosphate precipitation method (Graham and van der Eb, 1973) using pGEM plasmid as carrier DNA.
Plasmids
E2F1-luc(Wt) and E2F-luc (mE2F) reporter constructs have been described elsewhere (Smith et al., 1996; Johnson, 1995) . Mammalian plasmid expression vectors included pCMVRBP1-HA that was provided by Bill Kaelin (Kaelin, unpublished) , and pCMVRBP1DLCE-HA that was constructed by deleting residues 921-1056 of RBP1 coding region from pCMVRBP1-HA using restriction enzyme digests involving NsiI and KpnI. Plasmids expressing human pRB and p130, or the product of 12S Ad5 E1A mRNA were subcloned into pcDNA3 (Invitrogen). G5TKCAT reporter construct has been described elsewhere (Yew et al., 1994; Teodoro and Branton, 1997) . Gal4-RBP1(SV40) plasmid was generated from pCMVRBP1-HA by polymerase chain reaction using Vent DNA polymerase (New England Biolab) with primers speci®c for the RBP1 coding region. The ampli®ed products were digested with SmaI and XbaI restriction enzymes and subcloned in-frame with the Gal4 DNA binding domain of pSG424 which expresses Gal4 fusion proteins in mammalian cells under the SV40 promoter. Gal4-RBP1(CMV) plasmid was constructed by subcloning the HindIII digested fragment of Gal4-RBP1(SV40) plasmid into pcDNA3 which expresses proteins in mammalian cells under the CMV promoter. All the carboxy-terminal deletion mutants of Gal4-RBP1 were generated from restriction enzyme digests of the Gal4-RBP1(SV40) plasmid and subcloned into a modi®ed pcDNA3 construct containing stop codons inserted 3' of the multicloning cassette. Gal4-RBP1-DLCE plasmid was constructed by deleting residues 921 ± 1056 of RBP1 coding region from Gal4-RBP1(SV40) using restriction enzyme digests involving NsiI and KpnI. Gal4-RBP1-Rep plasmid was constructed by subcloning the restriction enzyme digested fragment that correspond to residues 388 ± 599 of the Gal4-RBP1 coding region into pSG424. Gal4-Ad5E1B55K plasmid was described previously (Teodoro and Branton, 1997) . All constructs made were con®rmed by sequencing using speci®c primers.
Cell lysis and electrophoretic mobility shift assay (EMSA)
CV-1 cells were harvested and whole cell extracts were prepared using (Corbeil et al., 1995; Corbeil and Branton, 1997) lysis buer (50 mM HEPES-KOH, pH 7.9, containing 0.4 M KCl, 0.1% (v/v) NP-40, 4 mM NaF, 4 mM NaVO 4 0.2 mM EDTA, 0.2 mM EGTA, 10% Glycerol (v/v), 1 mM DTT, 0.5 mM PMSF, 1 mg/ml pepstatin, 1 mg/ml leupeptin and 1 mg/ml aprotinin) and centrifuged for 45 min at 20 000 g. EMSA was performed using whole cell extracts and an E2F-speci®c oligonucleotide. GATT-TAAGTTTCGCGCCCTTTCTCAA, as described previously (Cao et al., 1992) , and double stranded oligonucleotides were labeled using a 32 P-dCTP and Klenow polymerase. EMSA was carried out in 20 ml reaction mixtures containing 10 ± 20 mg of whole cell extract in 20 mM HEPES-KOH (pH 7.9) containing 40 mM KCl, 1 mM MgCl 2 , 0.1 mM EGTA, 0.4 mM DTT, 4 mg BSA, 2.5% (v/v) Ficoll, 1 ± 2 mg of salmon sperm DNA, and labeled probe containing 20 000 ± 50 000 c.p.m. Antibody`supershift' experiments were performed by incubating extracts for 10 min on ice with 1 ± 2 mg of antisera recognizing p130 (C-20; Santa Cruz Biotechnology), pRB (896; provided by Peter Whyte, Corbeil et al., 1995) , p107 (SD9; Santa Cruz Biotechnology), or RBP1 (LY11; Decaprio, unpublished) . Reactions were incubated at room temperature for 30 min and then samples were loaded on a 4% polyacrylamide gel (30:1 polyacrylamide: bis-acrylamide) in 0.256 TBE and subjected to electrophoresis at 200 V for 2 h. Gels were dried and analysed by autoradiography using Kodak X-omat ®lm.
Western blot analysis of Gal4RBP1 mutants
Plasmids encoding dierent truncations of Gal4RBP1 were transfected into 293T or CHO cells using the standard calcium phosphate method. Cells were lysed using the same lysis buer described previously and protein content was determined using the Biorad reagent. 30 mg of protein for each sample were resolved by SDS ± PAGE using either a 7.5% or 10% polyacrylamide gel. Proteins were then transferred to PVDF membranes (Millipore) which were probed with Gal4DBD monoclonal antibody (RK5C1; Santa Cruz Biotechnology) and then by HRP-conjugated goat anti-mouse secondary antibody (Jackson Laboratories) and binding was detected by Enhanced Luminol Reagent (NEN Life Science). 35 S]; NEN Life Science) for 4 h. Cells were lysed with the same lysis buer described above. Cell lysates were precleared with protein G Sepharose (Pharmacia) for 2 h at 48C and 2 mg of either LY11 (anti-RBP1), IF8 (anti-RB; Santa Cruz Biotechnology), or HA.11 (anti-HA epitope; Babco) monoclonal antibodies were added to lysates along with 30 ml of protein G Sepharose for 12 h. Immunoprecipitated proteins were loaded onto a 7.5% polyacrylamide gel and subjected to SDS ± PAGE until the dye front ran o. Gels were ®xed by DMSO/PPO treatment and then dried and analysed by autoradiography using Kodak X-omat ®lm.
Chloramphenicol acetyltransferase (CAT), b-galactosidase and luciferase assays CAT and b-galactosidase assays were performed as described previously (Teodoro and Branton, 1997) . Luciferase assays were performed as described elsewhere (Wrana et al., 1992) .
Colony formation assay
CV-1 cells were transfected with 3 mg of DNA from plasmids expressing neo as well as RBP1, including pRcCMVRBP1-HA encoding an HA-tagged version of RBP126, pcDNA3Gal4RBP1 containing RBP1 fused to the Gal4 DNA-binding motif, and pcDNA3Gal4RBP1dl-747C encoding RBP1 lacking the Leu-X-Cys-X-Glu binding sequence. Cells were plated in medium containing 500 mg/ ml of G418 and allowed to grow for 2 weeks and then stained with crystal violet.
